In summary, these results experimentally identified RNF8 as a new target of miR-622 in breast cancer, revealing a new role for miR-622 in breast cancer tumorigenesis and verified our targets and functional analysis of miR-622. This evidence concerns the gene RNF8 and breast carcinoma.